NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice From Nasdaq That the Company Has Demonstrated Compliance With the Bid Price Requirement
Yahoo FinanceApr 18 08:32 ET
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
Yahoo FinanceApr 17 16:45 ET
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Moomoo 24/7Apr 1 19:50 ET
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
Yahoo FinanceMar 28 08:03 ET
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Yahoo FinanceMar 26 16:03 ET
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders
Yahoo FinanceMar 18 08:30 ET
NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales
Yahoo FinanceMar 12 07:49 ET
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in Its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Yahoo FinanceMar 4 08:30 ET
Positive Signs As Multiple Insiders Buy NRx Pharmaceuticals Stock
Yahoo FinanceMar 2 08:19 ET
NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together With Investor Commitment for Additional $1 Million
Yahoo FinanceFeb 27 08:54 ET
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of Its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Yahoo FinanceJan 22 06:48 ET
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis
Yahoo FinanceJan 16 06:48 ET
NRx Pharmaceuticals GAAP EPS of -$0.14
Seeking AlphaNov 14, 2022 06:55 ET
NRXP FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 21 Deadline in Securities Class Action - NRXP, NRXPW
Newsfile 15-Mar-2022 12:35 PMNew York, New York--(Newsfile Corp. - March 15, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceutical
NewsfileMar 15, 2022 12:44 ET
FCFS, VWAGY & NRXP Deadline Alerts: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Deadlines
ACCESSWIRE 11-Mar-2022 11:01 AMNEW YORK, NY / ACCESSWIRE / March 11, 2022 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following p
ACCESSWIREMar 11, 2022 11:08 ET
ROSEN, A TOP RANKED LAW FIRM, Encourages NRx Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - NRXP, NRXPW
Newsfile 10-Mar-2022 6:10 PMNew York, New York--(Newsfile Corp. - March 10, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals
NewsfileMar 10, 2022 18:20 ET
NRX INVESTOR NEWS: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSE, Encourages NRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NRXP, NRXPW
Newsfile 7-Mar-2022 4:45 PMNew York, New York--(Newsfile Corp. - March 7, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NRx Pharmaceuticals,
NewsfileMar 7, 2022 16:52 ET
NASDAQ TRADE HALT NRXPW.O HALT NEWS PENDING AT 06:01 PM
NASDAQ TRADE HALT NRXPW.O HALT NEWS PENDING AT 06:01 PM
reutersNov 4, 2021 18:06 ET
No Data
No Data